Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Tumor Immunotherapy01:27

Tumor Immunotherapy

463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational bottlenecks for biohybrid microrobots.

Science robotics·2026
Same author

A highly sensitive and simultaneous bifunctional fluorescent probe for detecting mitochondrial viscosity and nitroreductase activity in vivo.

Analytica chimica acta·2026
Same author

Light-switchable swarming of biohybrid microrobots.

Science advances·2026
Same author

A STING-adjuvanted outer membrane vesicle nanoparticle vaccine vs. <i>Klebsiella pneumoniae</i> elicits broad capsule-type cross-protection.

PNAS nexus·2026
Same author

Integrating Experiments and Simulations to Uncover Size-Dependent Bioactivity in Cellular Nanodiscs.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Light-Triggered Accelerated Degradation of Surface-Bound Chemical Agents.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: May 26, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.5K

Universal Prophylactic Antitumor Vaccination Using Stem Cell Membrane-Coated Nanoparticles.

Nishta Krishnan1, Jiarong Zhou1, Animesh Mohapatra1

  • 1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, 92093, USA.

Advanced Materials (Deerfield Beach, Fla.)
|February 24, 2025
PubMed
Summary

Researchers developed a novel cancer nanovaccine using induced pluripotent stem cell (iPSC) membranes. This broad-spectrum prophylactic vaccine trains the immune system to prevent cancer before it occurs.

Keywords:
cell membrane coatingcellular nanoparticleiPSConcofetal antigenprophylactic cancer vaccine

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.1K

Related Experiment Videos

Last Updated: May 26, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.5K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.1K

Area of Science:

  • Immunology
  • Nanotechnology
  • Oncology

Background:

  • Cancer vaccines aim to train the immune system against malignant cells.
  • Therapeutic cancer vaccines face challenges due to established tumor immunosuppression.
  • Previous research utilized cell membrane coating nanotechnology for vaccine development.

Purpose of the Study:

  • To develop a broad-spectrum prophylactic cancer nanovaccine.
  • To engineer a nanovaccine using induced pluripotent stem cell (iPSC) membranes.
  • To present oncofetal antigens for cancer prevention.

Main Methods:

  • Coating adjuvant-loaded nanoparticles with iPSC membranes.
  • Utilizing iPSC-derived oncofetal antigens for immune stimulation.
  • In vivo administration and evaluation in multiple murine tumor models.

Main Results:

  • The iPSC membrane-coated nanovaccine demonstrated potent immunostimulatory effects.
  • Strong antitumor immunity was elicited, inhibiting tumor growth across five models.
  • Effective inhibition was observed in a bilateral heterogeneous tumor model.

Conclusions:

  • An effective approach for engineering iPSC-based nanovaccines was demonstrated.
  • The nanovaccine shows broad-spectrum prophylactic potential against various cancers.
  • This technology offers a promising strategy for cancer prevention before disease onset.